Last reviewed · How we verify

IV acetaminophen & IV propofol — Competitive Intelligence Brief

IV acetaminophen & IV propofol (IV acetaminophen & IV propofol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic/antipyretic and sedative-hypnotic combination. Area: Anesthesia, Critical Care, Pain Management.

marketed Analgesic/antipyretic and sedative-hypnotic combination Anesthesia, Critical Care, Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

IV acetaminophen & IV propofol (IV acetaminophen & IV propofol) — Beth Israel Deaconess Medical Center. This is a combination of two separate drugs: acetaminophen (a non-opioid analgesic and antipyretic) and propofol (an intravenous sedative-hypnotic agent).

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
IV acetaminophen & IV propofol TARGET IV acetaminophen & IV propofol Beth Israel Deaconess Medical Center marketed Analgesic/antipyretic and sedative-hypnotic combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic/antipyretic and sedative-hypnotic combination class)

  1. Beth Israel Deaconess Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). IV acetaminophen & IV propofol — Competitive Intelligence Brief. https://druglandscape.com/ci/iv-acetaminophen-iv-propofol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: